fda glp-1 compounding crackdown news issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Despite FDA crackdown, unapproved GLP-1s

Ozempic and drugs like it, including Wegovy, Monjouro, and Zepbound, have been praised as game-changing medications for weight loss in qualified patients

doi: 10.1016/j.ctim.2019.102245 65 JamilianMAsemiZ

Anthony Puopolo, President, LifeMD Affiliated P.C.s, helped develop Triple Therapy to give patients more avenues for success

Table of Contents GLP-1 Medications and Surgery: Perioperative Considerations Glucagon-like peptide-1 (GLP-1) receptor agonists including semaglutide (Ozempic, Wegovy), dulaglutide (Trulicity), and liraglutide (Victoza, Saxenda) are widely prescribed for type 2 diabetes and weight management